The focus of the event is on cutting-edge enabling technologies, both post- and pre-commercialization, that expedite real-world research in synthetic chemistry. It aims to attract representation from major pharmaceutical and biotechnology companies, as well as academic institutions. The meeting’s scope has evolved to include developments in analytical equipment, automated synthesis process improvements, emerging technologies, and robotics. Themes also include flow chemistry, photochemistry, electrochemistry, and developments in lab automation.
- Dr. Garry Pairaudeau, Chief Technology Officer, Exscientia
- Prof. Jeffery Bode, ETH Zurich